Suppr超能文献

椎动脉支架置入术后二元再狭窄的发生率、风险和治疗。

Incidence, risk, and treatment of binary restenosis after vertebral artery stenting.

机构信息

Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

The Second Affiliated Hospital, University of South China, Hengyang, China.

出版信息

Catheter Cardiovasc Interv. 2020 Aug;96(2):404-409. doi: 10.1002/ccd.28906. Epub 2020 Apr 11.

Abstract

BACKGROUND

In-stent restenosis (ISR) is the major concern of vertebral artery stenting (VAS). We aimed to investigate the feasibility and outcome of redo angioplasty for ISR of vertebral artery.

METHOD

The patients were retrospectively reviewed for the significant ISR (>50%). Redo angioplasty including balloon angioplasty and stenting was performed for symptomatic ISR (>50%) or asymptomatic ISR (≥70%). The clinical follow-up was performed on the 1, 3, 6, and 12 months and then yearly in the clinic or by telephone. The angiographic follow-up was performed at 6-12 months after redo angioplasty.

RESULT

A total of 72 patients had significant ISR and 48 redo angioplasty (92.3%, 48/52) were successfully achieved with 13 located in the V4 and 35 in the ostium of vertebral artery. Twenty-six lesions were implanted by the second stent and the others received balloon angioplasty. No stroke or transient ischemic attack (TIA) occurred in the perioperative time. One patient died 2 months after redo angioplasty due to nonstroke cause. Redo angioplasty nonsignificantly decreased the stroke or TIA compared with medical treatment. Sixteen patients developed the binary restenosis, which was lower in the patients receiving stent implantation than balloon angioplasty.

CONCLUSION

Redo angioplasty was a feasible method for the ISR of VAS and redo stenting might be the first choice.

摘要

背景

支架内再狭窄(ISR)是椎动脉支架置入术(VAS)的主要关注点。我们旨在研究经皮血管成形术治疗椎动脉 ISR 的可行性和结果。

方法

回顾性分析狭窄率>50%的患者为明显 ISR;狭窄率>50%或≥70%的无症状 ISR 行球囊血管成形术和支架置入术。临床随访在 1、3、6 和 12 个月进行,之后每年在诊所或通过电话进行。血管造影随访在再血管成形术后 6-12 个月进行。

结果

共有 72 例患者存在明显的 ISR,其中 48 例(92.3%,48/52)成功进行了再血管成形术,其中 13 例位于椎动脉 V4 段,35 例位于椎动脉开口处。26 个病变采用第二个支架植入,其余采用球囊血管成形术。围手术期无卒中或短暂性脑缺血发作(TIA)发生。1 例患者在再血管成形术后 2 个月因非卒中原因死亡。与药物治疗相比,再血管成形术并未显著降低卒中或 TIA 的发生率。16 例患者发生了二元再狭窄,支架植入患者的再狭窄发生率低于球囊血管成形术患者。

结论

经皮血管成形术是治疗椎动脉 ISR 的一种可行方法,再次支架置入可能是首选方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验